- Home
- ELTX vs CEE Comparison
ELTX vs CEE Comparison
Compare ELTX & CEE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELTX
- CEE
- Stock Information
- Founded
- ELTX 2011
- CEE 1990
- Country
- ELTX United States
- CEE Germany
- Employees
- ELTX N/A
- CEE N/A
- Industry
- ELTX Biotechnology: Pharmaceutical Preparations
- CEE Finance Companies
- Sector
- ELTX Health Care
- CEE Finance
- Exchange
- ELTX Nasdaq
- CEE Nasdaq
- Market Cap
- ELTX 121.7M
- CEE 97.8M
- IPO Year
- ELTX N/A
- CEE N/A
- Fundamental
- Price
- ELTX $8.09
- CEE $15.47
- Analyst Decision
- ELTX Strong Buy
- CEE
- Analyst Count
- ELTX 2
- CEE 0
- Target Price
- ELTX $9.50
- CEE N/A
- AVG Volume (30 Days)
- ELTX 46.9K
- CEE 22.0K
- Earning Date
- ELTX 08-12-2025
- CEE 01-01-0001
- Dividend Yield
- ELTX N/A
- CEE 3.86%
- EPS Growth
- ELTX N/A
- CEE N/A
- EPS
- ELTX N/A
- CEE N/A
- Revenue
- ELTX N/A
- CEE N/A
- Revenue This Year
- ELTX N/A
- CEE N/A
- Revenue Next Year
- ELTX N/A
- CEE N/A
- P/E Ratio
- ELTX N/A
- CEE N/A
- Revenue Growth
- ELTX N/A
- CEE N/A
- 52 Week Low
- ELTX $3.70
- CEE $7.80
- 52 Week High
- ELTX $9.99
- CEE $10.32
- Technical
- Relative Strength Index (RSI)
- ELTX 62.14
- CEE 58.45
- Support Level
- ELTX $7.76
- CEE $15.38
- Resistance Level
- ELTX $8.94
- CEE $15.80
- Average True Range (ATR)
- ELTX 0.37
- CEE 0.35
- MACD
- ELTX -0.03
- CEE 0.06
- Stochastic Oscillator
- ELTX 51.09
- CEE 88.89
About ELTX Elicio Therapeutics Inc.
Elicio Therapeutics Inc is a clinical-stage biotechnology company pioneering the development of cancer immunotherapies for patients with limited treatment options and poor outcomes. Its proprietary Amphiphile, or AMP, platform delivers investigational immunotherapeutics directly to the brain center of the immune system the lymph nodes. Its focus is the development of cancer immunotherapies against biologically validated but hard-to-drug targets that can be activated through lymph node trafficking. Elicio is engineering lymph node-targeted AMPlifiers, immunomodulators, adjuvants, and vaccines for an array of aggressive cancers. It has developed its cancer vaccine product candidates to target biologically validated tumor mutation drivers using known neoantigens.
About CEE The Central and Eastern Europe Fund Inc. (The)
CENTRAL & EASTERN EUROPE FUND, INC. is a closed-end management investment company. The Fund's objective is to seek long-term capital appreciation. It invests in the equity or equity-linked securities of issuers domiciled in Central and Eastern Europe.